Melanoma kills 8,500 Americans a year. An mRNA vaccine may help stop it from coming back.
Moderna and Merck are advancing an experimental mRNA vaccine aimed at preventing melanoma — the deadliest form of skin cancer — from returning after surgery, with FDA approval sought for next year.